The Healthtech Podcast

This week, James is joined by Dr. Kerstin Papenfuss, Director of Pharma at Deep Science Ventures. Deep Science Ventures is pioneering a new approach to building healthtech companies from the ground up, focusing on four key outcomes: restorative cultivation, scaling intelligence, reversing global heating, and curative therapeutics. Kerstin has over a decade of experience in leadership roles at impact-driven organisations advancing medicine and therapeutics and has been leading the pharma sector at Deep Science Ventures for the past four years.https://www.deepscienceventures.com/Apply to be a guest: www.thehealthtechpodcast.comSubscribe to Healthtech Pigeon 🐦:www.healthtechpigeon.comGet in touch with James: www.jamessomauroo.comLearn more about SomX for your healthtech company at somx.health

Join Claus Torp Jensen, a technologist and storyteller with a rich background in healthcare at Teladoc Health and Memorial Sloan Kettering. He dives into his journey from coding hobbyist to healthtech leader and emphasizes the importance of storytelling in driving change. Claus discusses board governance in healthtech startups, urging founders to adopt a collaborative approach. He also envisions a future of ambient healthcare that balances technology with personal choice, aiming for a more personalized and patient-centric experience.

George Murgatroyd, VP of Digital Technologies at Medtronic, shares insights from over 20 years in the NHS. He discusses the intersection of philosophy and technology, particularly the ethical implications of AI in healthcare. Murgatroyd highlights the need for modern systems to combat workplace morale issues, linking them to patient care quality. He also addresses the challenges junior doctors face with evolving tech and emphasizes the potential of digital innovations to transform patient experiences. A blend of expertise and optimism shapes this engaging discussion.

Cosmo Feilding Mellen, co-founder and CEO of Beckley Psytech, is a pioneer in psychedelic medicine aimed at treating neuropsychiatric disorders. He discusses the revival of psychedelic research and its historical context, the fascinating intersection of anesthetics and psychedelics in psychiatry, and the innovative next-gen compounds being developed. Mellen also explores the cultural shift towards destigmatizing mental health, envisioning psychedelics as integral to future psychiatric care. Join the discussion on the exciting evolution of mental health treatment!

This Sunday, James is joined by Nara Moripen, co-founder and CEO of Pal as she gives us her quick tips for entrepreneurs. Apply to be a guest: www.thehealthtechpodcast.comSubscribe to Healthtech Pigeon 🐦:www.healthtechpigeon.comGet in touch with James: www.jamessomauroo.comLearn more about SomX for your healthtech company at somx.health

This week, James is joined by Nara Moripen, the co-founder & CEO of Pal. Pal is a digital palliative care solution that helps families navigate the world of serious illness, and gives them the practical tools and support needed to care for their loved ones.Learn more: http://www.palhelps.comApply to be a guest: www.thehealthtechpodcast.comSubscribe to Healthtech Pigeon 🐦:www.healthtechpigeon.comGet in touch with James: www.jamessomauroo.comLearn more about SomX for your healthtech company at somx.health

Devika Wood, Chief Commercial Officer at Brain+, has an impressive background in healthcare and tech, having co-founded several successful companies. In the discussion, she shares insights on digitized cognitive stimulation therapy for dementia, emphasizing its potential to revolutionize care. Devika explores the emotional challenges of startup leadership, the importance of community support for women, and the critical role of data in healthtech innovation. Her journey reflects passion and resilience, inspiring others in the entrepreneurial space.

This week, James is joined by Dr. Meriem Sefta, PhD, Chief Diagnostics Officer at Owkin. Owkin is the first end-to-end AI-biotech company on a mission to understand complex biology and ensure every patient gets the right treatment using AI trained on world-class patient data through privacy-enhancing technologies.Learn more: https://www.owkin.com/diagnostics-approachApply to be a guest: www.thehealthtechpodcast.comSubscribe to Healthtech Pigeon 🐦:www.healthtechpigeon.comGet in touch with James: www.jamessomauroo.comLearn more about SomX for your healthtech company at somx.health

This week, James is joined by George McBride, co-founder and COO of Clerkenwell Health a psychedelic-specialty clinical research organisation and site network headquartered in London. George is a commercial barrister turned drug policy reform advocate and entrepreneur. He's played in a key role in the campaign to legalise medical cannabis in the UK at the NGO Volteface before founding Europe’s leading cannabis advisory firm, Hanway Associates and industry conference Cannabis Europa. Learn more about Clerkenwell Health: https://www.clerkenwellhealth.com/Apply to be a guest: www.thehealthtechpodcast.comSubscribe to Healthtech Pigeon 🐦:www.healthtechpigeon.comGet in touch with James: www.jamessomauroo.comLearn more about SomX for your healthtech company at somx.health

This week, James is joined by Sokratis Papafloratos, CEO and founder of Numan. After founding and exiting previous companies, Sokratis founded Numan in 2018 to provide men with access to treatment for erectile dysfunction. His journey towards founding the company was fuelled by a personal realisation of the underserved nature of men's health and a desire to leverage technology for positive behavioural change and destigmatisation. Six years later, Numan has scaled and evolved into the UK’s biggest men’s digital healthcare ecosystem providing support for more than half a million people across a wide range of health conditions and concerns.Learn more: https://www.numan.com/Apply to be a guest: www.thehealthtechpodcast.comSubscribe to Healthtech Pigeon 🐦:www.healthtechpigeon.comGet in touch with James: www.jamessomauroo.comLearn more about SomX for your healthtech company at somx.health